So you may be hearing that there are many new treatment available for people who are infected by hepatitis C. Unfortunately, they are very expensive and some are not yet covered.
The new one that everyone is talking about is Harvoni by Gilead Sciences Inc. is the first once-daily single tablet regimen for the treatment of chronic hepatitis C genotype 1 infection in adults. Treatment can be 8, 12 or 24 weeks. There is a criteria to be able to take this treatment.
For more information, please visit www.catie.ca/en/news/hepcinfo-updates/2014-12-03 or talk to one of our hepatitis C treatment nurses (Keri or Kelsey).